Suchergebnisse - "Tian, Hao"

PubPharm (1.365)

1

Cuproptotic nanoinducer-driven proteotoxic stress potentiates cancer immunotherapy by activating the mtDNA-cGAS-STING signaling

enthalten in: Biomaterials | 2024

von Yu, X. | Li, B. | Yan, J. | +5

2

Safety and efficacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial) : a single-arm, phase 2 trial

enthalten in: EClinicalMedicine | 2024

von Liang, Y. | Liu, J. | Ge, J. | +14

3

Tet-mediated DNA methylation dynamics affect chromosome organization

enthalten in: Nucleic acids research | 2024

von Tian, H. | Luan, P. | Liu, Y. | +1

4

Correlation between Disc Imaging Observations and Clinical Efficacy after Percutaneous Endoscopic Lumbar Discectomy : A 1-Year Follow-up Study

enthalten in: Orthopaedic surgery | 2024

von Li, B. | Wang, T. | Huang, Y. | +9

5

Outcomes of thoracic endovascular aortic repair with physician-manufactured partial micropore stent grafts for aortic arch pathologies

enthalten in: Journal of vascular surgery | 2024

von Huang, J. | Tian, H. | Chen, Z. | +3

6

Indirect comparison of finerenone and SGLT 2 inhibitors in established chronic kidney disease: evidence based on Bayesian methods

enthalten in: ResearchSquare.com | 2024

von Chen, H. | Li, D. | Meng, R. | +2

7

Host proteins interact with viral elements and affect the life cycle of highly pathogenic avian influenza A virus H7N9

enthalten in: Heliyon | 2024

von Yu, D. | Wu, X. | Weng, T. | +7

8

Research progress of circadian rhythm in cardiovascular disease : A bibliometric study from 2002 to 2022

enthalten in: Heliyon | 2024

von Tian, H. | Zhao, X. | Zhang, Y. | +1

9

Synthesis and characterization of core-shell high-nickel cobalt-free layered LiNi0.95Mg0.02Al0.03O2Li2ZrO3 cathode for high-performance lithium ion batteries

enthalten in: Journal of colloid and interface science | 2024

von Wang, Z. | Li, L. | Heo, H. | +9

10

High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionation

enthalten in: Acta pharmaceutica Sinica. B | 2024

von Fan, Y. | Wang, J. | Jian, J. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[137]